Stay updated on Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.

Latest updates to the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page footer shows Revision: v3.6.5, replacing the previous Revision: v3.6.4, indicating a new version of the page content.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page, indicating a minor update or patch to the study details page. This change does not alter any visible content or functionality.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision tag (v3.6.3) appears, replacing the previous v3.6.2. This signals a recent update to the page content.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, signaling a minor site release. There are no changes to study details or user-facing content reflected in this update.SummaryDifference0.1%

- Check75 days agoChange DetectedThe study page adds a recruitment status of no longer looking for participants and introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also includes a revision update (Revision: v3.6.0) and adjusts the Intervention/Treatment header, while the older header (Intervention / Treatment) and previous revision note (v3.5.5) are removed.SummaryDifference0.4%

- Check82 days agoChange DetectedThe page now displays a new site revision (v3.5.5), replacing the previous revision (v3.5.4). This indicates an underlying platform update rather than a modification to the study data.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.